Trial Status: Open
Enrolling through a Single clinic to be held on 3/7/2020
Ethos Discovery de novo Study
Ethos Discovery is pursuing an investigation into the use of a cell-based therapy for NME in pugs. This trial will be utilizing a previously defined genetic mutation to identify pugs that are at risk for developing NME. Prior to this trial a pilot study has been launched, which will determine the feasibility of recruiting Pugs for blood sample collection from clinically normal dogs to validate the genomic assay. It will also allow us to better define the prevalence of this mutation in a given population of pugs. This feasibility data will be important for an ongoing NIH grant submission, which will fund a follow up project on a Cell-Based Therapy for Necrotizing Meningoencephalitis in Pugs.